Track topics on Twitter Track topics that are important to you
We are a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Our primary focus is on the development of oral therapeutics for the treatment of human immunodeficiency virus, or HIV, hepatitis B virus, or HBV, and hepatitis C virus, or HCV. Our research and development efforts focus on a class of compounds known as nucleoside analogs, which act to inhibit the natural enzymes required for viral replication.
303-A College Road East
United States of America
Phone: (609) 613-4100
Fax: (609) 613-4150
Pharmasset announce promising results for experimental Hepatitis C therapy
Speculation is mounting that Gilead could be on the acquisition trail after the company posted Q2 results showing sliding sales of its hepatitis C medicines, Sovaldi and Harvoni. Sales of the drugs, ...
U.S. District Judge Beth Labson Freeman said Gilead proved that in the process of applying for its patents, Merck used confidential information from Pharmasset
A look at today's forthcoming news stories: Sales up but profits down for Pfizer and Merck & Co after mega-mergers; disappointment for Dainippon as epilepsy drug fails to win approval, and US drug dev...
A Florida man admitted to conducting insider trading based on a tip he received from a former Morgan Stanley broker about Gilead Sciences Inc's planned $11.2 billion purchase of Pharmasset Inc in 2011...
A federal judge reversed a jury's decision in March that had upheld two HCV patents and had awarded $200 million in damages to Merck & Co. Inc. (NYSE:MRK) and Ionis Pharmaceuticals Inc. (NASDAQ:IONS) ...
A US court has ruled Gilead must pay $200 million in damages to Merck & Co and Ionis Pharmaceuticals, for infringing upon a patent relating to development of medicines including its big-selling dr...
We are a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Our primary focus is on the development of oral therapeut...
We have published hundreds of Pharmasset, Inc. news stories on BioPortfolio along with dozens of Pharmasset, Inc. Clinical Trials and PubMed Articles about Pharmasset, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmasset, Inc. Companies in our database. You can also find out about relevant Pharmasset, Inc. Drugs and Medications on this site too.
Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...